|
|
 |
|
Viewing report
|
|
|
|
Competitor Analysis: Cancer Vaccines
La Merie Publishing, Nov 2011, Pages: 151
The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines against cancer. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
Projects are listed according to their main antigenic constituents:
- peptides
- recombinant proteins
- antibody
- DNA (plasmid, expression vector)
- RNA
- virus-like particles (VLP)
- dendritic cells
- tumor cells (tumor cell lines)
- others.
The report includes a compilation of currently active projects in research and development for prophylaxis and therapy of cancer. In addition, the report lists company-specific R&D pipelines of cancer vaccines.
Competitor projects are listed in a tabular format providing information on:
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Company
- Product Category
- Indication
- R&D Stage
- additional comments with a hyperlink leading to the source of information.
ABOUT COMPETITOR ANALYSIS SERIES:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
|
|
|
|
